Parker Brewster is a distinguished entrepreneur and innovator with a profound commitment to positively transforming the world. His entrepreneurial journey began in high school, where he developed a groundbreaking alternative to angioplasty. This invention, which has since been awarded a utility patent, was the cornerstone for his first venture, Innovative Heart Technologies, where he served as founder and CEO.
Holding a Bachelor’s degree in Engineering and a Master’s degree in Mechanical Engineering with a focus on Biomedical applications, Parker is currently completing his PhD in Biomedical Engineering. In parallel, he contributes as the Vice President of Research and Development for a company pioneering the design of new drug delivery implants.
Parker’s vast experience encompasses roles as both a participant and mentor in accelerator programs, paid and volunteer work with venture capital firms, and a notable fellowship with the National Institutes of Health (specifically within the National Center for Advancing Translational Sciences).
These experiences have equipped him to mentor students, provide consultancy to startups, drive forward-thinking innovation, and develop comprehensive undergraduate and MBA courses centered on launching technology ventures. To date, Parker has successfully mentored over 20 startups and holds board positions in four additional companies.
The founding of BMTT (Biomedical Think-Tank) represents Parker’s vision to introduce and nurture clinical entrepreneurship within students from all backgrounds. His goal is to leverage this platform to commence life-saving interventions for patients, embodying his commitment to harnessing innovation for the greater good.
Anna Owens stands out as a trailblazer in the intersection of biotechnology and business, poised to become the first individual at the University of Mississippi to earn dual degrees in Biomedical Engineering and General Business.
Her decision to pursue such an ambitious academic path is a testament to her unwavering commitment to making significant contributions in the field of translational sciences. Anna’s journey in research commenced in the esteemed laboratory of Dr. Thomas Werfel, where she rapidly evolved into a pivotal leadership figure.
Her tenure in Dr. Werfel’s lab was marked by her pioneering efforts in conducting novel studies, particularly focusing on drug delivery implants and their implications in women’s and reproductive health. This work not only underscores her scientific acumen but also highlights her dedication to addressing critical areas in healthcare that often receive less attention. Initially joining BMTT as an engaged student, Anna’s profound interest and exceptional skills quickly became apparent, leading her to seek and assume a more impactful role within the organization.
Her unique blend of engineering expertise and business acumen positions her perfectly to bridge the gap between technological innovation and commercial viability. Anna’s contribution to BMTT goes beyond her academic achievements; she brings a visionary approach to the team, where her insights are invaluable in steering the organization towards groundbreaking developments in healthcare.
Her role in BMTT is not just as a founder but as a catalyst for change, fostering an environment where innovative ideas can flourish and transform patient care.
Please reach out to us here!